via University of Pittsburgh School of Medicine
Today in Science, researchers at the University of Pittsburgh School of Medicine describe a new method to extract tiny but extremely powerful SARS-CoV-2 antibody fragments from llamas, which could be fashioned into inhalable therapeutics with the potential to prevent and treat COVID-19.
These special llama antibodies, called “nanobodies,” are much smaller than human antibodies and many times more effective at neutralizing the SARS-CoV-2 virus. They’re also much more stable.
“Nature is our best inventor,” said senior author Yi Shi, Ph.D., assistant professor of cell biology at Pitt. “The technology we developed surveys SARS-CoV-2 neutralizing nanobodies at an unprecedented scale, which allowed us to quickly discover thousands of nanobodies with unrivaled affinity and specificity.”
To generate these nanobodies, Shi turned to a black llama named Wally—who resembles and therefore shares his moniker with Shi’s black Labrador.
Shi and colleagues immunized the llama with a piece of the SARS-CoV-2 spike protein and, after about two months, the animal’s immune system produced mature nanobodies against the virus.
Using a mass spectrometry-based technique that Shi has been perfecting for the past three years, lead author Yufei Xiang, a research assistant in Shi’s lab, identified the nanobodies in Wally’s blood that bind to SARS-CoV-2 most strongly.
Then, with the help of Pitt’s Center for Vaccine Research (CVR), the scientists exposed their nanobodies to live SARS-CoV-2 virus and found that just a fraction of a nanogram could neutralize enough virus to spare a million cells from being infected.
These nanobodies represent some of the most effective therapeutic antibody candidates for SARS-CoV-2, hundreds to thousands of times more effective than other llama nanobodies discovered through the same phage display methods used for decades to fish for human monoclonal antibodies.
Shi’s nanobodies can sit at room temperature for six weeks and tolerate being fashioned into an inhalable mist to deliver antiviral therapy directly into the lungs where they’re most needed. Since SARS-CoV-2 is a respiratory virus, the nanobodies could find and latch onto it in the respiratory system, before it even has a chance to do damage.
In contrast, traditional SARS-CoV-2 antibodies require an IV, which dilutes the product throughout the body, necessitating a much larger dose and costing patients and insurers around $100,000 per treatment course.
“Nanobodies could potentially cost much less,” said Shi. “They’re ideal for addressing the urgency and magnitude of the current crisis.”
In collaboration with Cheng Zhang, Ph.D., at Pitt, and Dina Schneidman-Duhovny, Ph.D., at the Hebrew University of Jerusalem, the team found that their nanobodies use a variety of mechanisms to block SARS-CoV-2 infection. This makes nanobodies ripe for bioengineering. For instance, nanobodies that bind to different regions on the SARS-CoV-2 virus can be linked together, like a Swiss army knife, in case one part of the virus mutates and becomes drug-resistant.
“As a virologist, it’s incredible to see how harnessing the quirkiness of llama antibody generation can be translated into the creation of a potent nanoweapon against clinical isolates of SARS-CoV-2,” said study coauthor and CVR Director Paul Duprex, Ph.D.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Llama nanobodies
- 5 easy ways to run an LLM locally
This is also a quick option to try some new specialty models such as Meta's new Llama 3, which is tuned for coding, and SeamlessM4T, aimed at text-to-speech and language translations. Running your ...
- Why Llama 3 is changing everything in the world of AI
And now, Meta’s Llama LLM (large language model) is becoming an increasingly important player in the game, especially with its open-source nature. Meta recently made a big splash with the launch ...
- Llama 3, the powerhouse behind Meta AI: All you need to know about it
The training data for Llama 3 consists of over 15 trillion tokens, sourced from publicly available data, making it seven times larger than the dataset used for Llama 2. Meta is stepping up its ...
- How Meta's Llama 3 will be integrated into its AI assistant
Meta is upping the ante in the artificial intelligence race with the launch of two Llama 3 models and a promise to make Meta AI readily available across all its platforms. The tech giant on ...
- Meta’s Llama 3 AI assistant is now live on Facebook, Instagram and WhatsApp — and it’s shockingly fast
The company has invested heavily in its Llama AI model and has now released Llama 3, which is even more powerful than the previous versions. In fact, Meta calls it "the most intelligent AI ...
Go deeper with Google Headlines on:
Llama nanobodies
[google_news title=”” keyword=”llama nanobodies” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Inhalable therapeutics to prevent and treat COVID-19
- Study reveals how COVID-19 vaccines prevent severe disease
A study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.
- New research strengthens case to treat COVID-19 with metformin, not ivermectin
MINNEAPOLIS — Patients with COVID-19 had lower viral loads if treated ... point” that convinces doctors to prescribe metformin to treat COVID, said Dr. Carolyn Bramante, the lead U researcher ...
- University of Minnesota strengthens case to treat COVID-19 with metformin, not ivermectin
Patients with COVID-19 had lower viral loads if treated with ... point" that convinces doctors to prescribe metformin to treat COVID, said Dr. Carolyn Bramante, the lead U researcher of the ...
- An effective treatment for COVID-19 is underused
By Nicholas Van Sickles University of Kentucky A safe and effective medication designed to prevent mild-to-moderate COVID-19 infections from becoming more dangerous has been available for almost two ...
- Can Neosporin Protect You From Getting COVID-19?
On its website, the maker of Neosporin says that the product has not "been tested or formulated to prevent against COVID-19 or any other virus," and also note that they do not advise putting the ...
Go deeper with Google Headlines on:
Inhalable therapeutics to prevent and treat COVID-19
[google_news title=”” keyword=”inhalable therapeutics to prevent and treat COVID-19″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]